Celtic Pharma And Russia's Rusnano Set Up Pro Bono Bio, A New Firm With Philanthropic Objectives
This article was originally published in The Pink Sheet Daily
Executive Summary
An Anglo-Russian company, Pro Bono Bio, launches new analgesic and will price its products according to ability to pay.